The phrase "availability of genome data" is correct and usable in written English.
You can use it when discussing the accessibility or presence of genomic information in a scientific or research context.
Example: "The availability of genome data has significantly advanced our understanding of genetic diseases."
Alternatives: "access to genomic data" or "presence of genome information".
The well-established knowledge and the availability of genome data have led to its versatile use as a cell factory for many industrial products (Ostergaard et al. 2000).
The availability of genome data has unquestionably revolutionized fungal research.
Despite increased availability of genome data, the attribution of putative functions to homologous genes annotations are at times too simple and errors can occur with the consequence of incorrect scientific dogmas.
At the genome level, the potential availability of genome data from the polyploid species may provide insight into questions of chromosome segregation and silencing.
Another reason is indeed the spare availability of genome data that makes de novo sequencing necessary as shown for proteins 04-ESI and 05-ESI.
Increasing availability of genome data linked or linkable to metadata through online social networks and services adds one additional layer of complexity to the protection of genome privacy.
The availability of this massive amount of genome data has been both a boon and a major challenge for biologists.
Recent developments in high-throughput technology for studying proteomes and the public availability of the genome data of different insect species allowed a comparative study of the glycoproteins present in the different insect species.
The availability of intraspecies genome data from two strains of Campylobacter jejuni [ 19, 20], has provided us with the opportunity to examine the quantitative relationship between the LR and probe/target identity (PTI) using our C. jejuni microarray.
Undoubtedly, bias might be present as pathogenic E. coli strains have higher level of public interest, and hence the availability of their genome data might be more compared to non-pathogenic E. coli.
The availability of CHO genome data as well as the advancement of omics tools and in silico modelling of mammalian systems have also identified target genes with diverse array of functions to potentially improve the titer of biopharmaceuticals [ 9, 17, 18].
